Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 June 2018

Greek is available via eTranslation, the European Commission's machine translation service.

Translate to Greek | Important information about machine translation

Date

Δευτέρα, 11 Ιούνιος 2018, Ολοήμερο

Τόπος

European Medicines Agency, Amsterdam, the Netherlands

The Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

Documents

български (BG) (254.09 KB - PDF)

Προβολή

español (ES) (223.77 KB - PDF)

Προβολή

čeština (CS) (245.83 KB - PDF)

Προβολή

dansk (DA) (220.97 KB - PDF)

Προβολή

Deutsch (DE) (225.02 KB - PDF)

Προβολή

eesti (ET) (219.98 KB - PDF)

Προβολή

ελληνικά (EL) (260.1 KB - PDF)

Προβολή

français (FR) (225.33 KB - PDF)

Προβολή

hrvatski (HR) (239.57 KB - PDF)

Προβολή

italiano (IT) (222.54 KB - PDF)

Προβολή

latviešu (LV) (252.56 KB - PDF)

Προβολή

lietuvių (LT) (244.9 KB - PDF)

Προβολή

magyar (HU) (246.89 KB - PDF)

Προβολή

Malti (MT) (250.25 KB - PDF)

Προβολή

Nederlands (NL) (223.78 KB - PDF)

Προβολή

polski (PL) (249.58 KB - PDF)

Προβολή

português (PT) (224.7 KB - PDF)

Προβολή

română (RO) (248.09 KB - PDF)

Προβολή

slovenčina (SK) (244.56 KB - PDF)

Προβολή

slovenščina (SL) (241.23 KB - PDF)

Προβολή

suomi (FI) (222.25 KB - PDF)

Προβολή

svenska (SV) (221.21 KB - PDF)

Προβολή

Multimedia

The PRAC held a public hearing on quinolone and fluoroquinolone antibiotics on 13 June 2018.

The hearing was broadcast live on 13 June from 13:00 - 18:00 (UK time).

The video recording is available.

Share this page